EYEGATE PHARMACEUTICALS INC's ticker is EYEG and the CUSIP is 30233M503. A total of 19 filers reported holding EYEGATE PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $12,182,000 | -26.9% | 3,346,601 | 0.0% | 0.22% | -43.1% |
| Q1 2021 | $16,666,000 | +86.2% | 3,346,601 | +84.3% | 0.38% | +26.0% |
| Q4 2020 | $8,950,000 | +25.8% | 1,815,500 | 0.0% | 0.30% | +17.8% |
| Q3 2020 | $7,117,000 | -18.5% | 1,815,500 | 0.0% | 0.26% | -32.6% |
| Q2 2020 | $8,733,000 | -7.5% | 1,815,500 | 0.0% | 0.38% | -34.4% |
| Q1 2020 | $9,441,000 | -47.4% | 1,815,500 | +1.3% | 0.58% | -43.6% |
| Q4 2019 | $17,961,000 | +112.9% | 1,792,500 | 0.0% | 1.04% | +85.3% |
| Q3 2019 | $8,438,000 | – | 1,792,500 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,815,500 | $8,950,000 | 0.30% |
| Sterling Financial Planning, Inc. | 1,171 | $6,000 | 0.01% |
| UBS Group AG | 3,991 | $20,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 468 | $2,000 | 0.00% |
| US BANCORP \DE\ | 2,710 | $13,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 34 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 12,656 | $62,000 | 0.00% |
| North Star Investment Management Corp. | 20 | $0 | 0.00% |
| MORGAN STANLEY | 466 | $2,000 | 0.00% |